MedTrace Logo

Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder

NCT01635569 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2023-05-12

No results posted yet for this study

Summary

Obsessive-Compulsive Disorder (OCD) is a common neuropsychiatric illness beginning in childhood. Effective OCD treatments include cognitive-behaviour therapy (CBT) and medications but access to treatment is difficult and does not systematically include parents. The investigators will evaluate clinical and neural effects of Group-based Family CBT (GF-CBT), via a case-control study including: Group 1 - OCD cases receiving GF-CBT (N=90); Group 2 - OCD waitlist cases (N=90). Effects will be measured between baseline and completion of 12 GF-CBT sessions: comparing OCD severity and functioning changes between Groups 1 and 2.

Conditions

  • Obsessive-compulsive Disorder

Interventions

BEHAVIORAL

Group-based family cognitive-behavioural therapy

Baseline and post-12 sessions

OTHER

Waitlist

Baseline and post-12 sessions

Sponsors & Collaborators

  • Michael Smith Foundation for Health Research

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • S. Evelyn Stewart, MD · University of British Columbia

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-01
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01635569 on ClinicalTrials.gov